13F Data
13F filer · CIK 1728001

Athyrium Capital Management, LP

New York, NY · filing since Q4 2017 · last filing Nov 12, 2024
Reported value
$8.7M
$-24.9M vs prior
Positions
2
New / sold out
0 / 1
Added / reduced
0 / 0
Turnover
0.0%
buys $0 · sells $22.2M
Top-10 weight
100.0%

Biggest buys vs Q2 2024

No new or increased positions this quarter.

Biggest sells vs Q2 2024

ChangeSecurityShares changeChange %Est. trade value
Sold outCOHERUS BIOSCIENCES INC-30,000,000-100.0%$-22.2M

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2017: $169.1MQ1 2018: $163.3MQ2 2018: $92.5MQ3 2018: $125.2MQ4 2018: $103.8MQ1 2019: $97.9MQ2 2019: $8.5MQ3 2019: $5.1MQ4 2020: $207.5MQ1 2021: $197.8MQ2 2021: $239.9MQ3 2021: $157.7MQ4 2021: $280.5MQ1 2022: $281.3MQ2 2022: $237.8MQ3 2022: $267.0MQ4 2022: $237.9MQ1 2023: $279.1MQ2 2023: $154.1MQ3 2023: $113.6MQ4 2023: $68.8MQ1 2024: $72.8MQ2 2024: $33.5MQ3 2024: $8.7M
Q4 2017Q3 2024

Holdings · Q3 2024

#SecuritySharesValueWeight
1Biora Therapeutics Inc.COM NEW10,929,762$5.5M63.12%
2PUMA BIOTECHNOLOGY INCCOM1,256,411$3.2M36.88%